Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935514 · ClinicalTrials.gov registry record · NA
Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT05935514 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 152 participants.
The verdict
NCT05935514, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
This study is a randomized clinical trial with the primary aim examining the efficacy of a novel integrated solution of a digitally delivered behavioral weight management program tailored for diabetes utilizing a continuous glucose monitor (CGM) built into the WW digital platform for adults with type 2 diabetes (T2D) for the reduction of HbA1c.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL WW Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2023-08-22 |
| Est. Completion | 2025-10-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05935514
The ClinicalTrials.gov registry entry for NCT05935514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT05935514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05935514 about?
NCT05935514 is a clinical study titled "Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring". This study is a randomized clinical trial with the primary aim examining the efficacy of a novel integrated solution of a digitally delivered behavioral weight management program tailored for diabetes utilizing a continuous glucose monitor (CGM) built into the WW digital platform for adults with typ...
What is the current status of trial NCT05935514?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2023-08-22. Estimated completion is 2025-10-23.
What interventions are being tested in trial NCT05935514?
The interventions under investigation include: Usual Care (BEHAVIORAL), WW Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05935514?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.